Quintiles
Quintiles Transnational is a pharmaceutical services company offering clinical, commercial, consulting and capital services. The Quintiles network consists of more than 20,000 employees in 60 countries.
Quintiles manages clinical trials on behalf of pharmaceutical customers, and provides the following services:
- Management of clinical trials, data, projects and providing laboratory services
- Providing customers with sales force, product and brand solutions
- Providing data-driven recommendations to help customers achieve success
- Creating strategic partnerships through financing and operational solutions
Quintiles helped develop or commercialize all of 2009's top 50 best selling drugs or compounds and nearly 90% of all breakthrough products released on the market between 1996 and 2008.[1]
History
Quintiles was founded in 1982 by Dennis Gillings, Ph.D., CBE, then a professor of biostatistics at the University of North Carolina, Chapel Hill.[2]
Key Dates:
- 1974: Dennis Gillings signs first contract to provide statistical and data management consulting for pharmaceutical clients.
- 1982: Quintiles, Inc., is incorporated in North Carolina.
- 1990: Quintiles Pacific Inc. and Quintiles Ireland Ltd. established
- 1991: Quintiles GMBH established in Germany; Quintiles Laboratories Ltd. established in Atlanta, Georgia
- 1996: Quintiles buys Innovex Ltd. and BRI International Inc., becoming the world's largest CRO[3]
- 1997: Quintiles goes public, completing successful secondary stock offering.
- 1998: Quintiles is the first company in industry to break the $1 billion mark, when it reports net revenues of $1.19 billion.
- 1999: Company joins the S&P 500 Index.
- 2003: Board of Directors agrees to merge with Pharma Services Holdings Inc; Quintiles becomes a private company.
- 2009: Quintiles opens new corporate headquarters in Durham, North Carolina
- 2010: Quintiles opens new European headquarters in the UK and establishes operations in East Africa.
- 2011: Quintiles buys Advion Biosciences, a bioanalytical lab based out of Ithaca, New York
References
- ^ EvaluatePharma, Top 100 Drugs 2009, April 14, 2010
- ^ "Money, Math and Medicine". Forbes Magazine. November 22, 2010. http://www.forbes.com/forbes/2010/1122/private-companies-10-quintiles-dennis-gillings-money-medicine.html. Retrieved April 14, 2011.
- ^ "High-Flying Quintiles to Buy Innovex in $747.5 Million Deal". New York Times. October 8, 1996. http://select.nytimes.com/gst/abstract.html?res=FB0C11FE3D5A0C7B8CDDA90994DE494D81. Retrieved April 14, 2011.
External links